Location History:
- Melbourne, AU (1994)
- Westmeadows, AU (2005 - 2008)
Company Filing History:
4 out of 1,332 
3 out of 525 
1 out of 267 
Years Active: 1994-2008
Title: Thomas Charles Elleman: Innovator in EGF Receptor Research
Introduction
Thomas Charles Elleman is a notable inventor based in Westmeadows, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of truncated EGF receptor molecules. With a total of 4 patents, his work has implications for cancer research and treatment.
Latest Patents
Elleman's latest patents focus on truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF-α. These inventions not only enhance the understanding of EGF receptor interactions but also provide methods for screening EGF receptor ligands. Furthermore, they offer innovative approaches to treatment involving these molecules.
Career Highlights
Throughout his career, Elleman has worked with prestigious organizations, including the Commonwealth Scientific and Industrial Research Organisation and the Ludwig Institute for Cancer Research Limited. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations
Elleman has collaborated with esteemed colleagues, including Robert Nicholas Jorissen and Thomas Peter John Garrett. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Thomas Charles Elleman is a distinguished inventor whose work on EGF receptor molecules has the potential to impact cancer treatment significantly. His contributions to biotechnology and collaboration with other researchers highlight his commitment to advancing scientific knowledge.